LINGO1 and Alzheimer disease: LINGO1, a negative regulator of BDNF-NTRK2-mediated neurotrophic signaling [65, 66] that has been implicated in axonal and synaptic loss [67], was consistently upregulated in AD but downregulated in resilience (Fig. 2B, Table S13).